447 related articles for article (PubMed ID: 20717926)
1. Glutamate preferentially suppresses osteoblastogenesis than adipogenesis through the cystine/glutamate antiporter in mesenchymal stem cells.
Takarada-Iemata M; Takarada T; Nakamura Y; Nakatani E; Hori O; Yoneda Y
J Cell Physiol; 2011 Mar; 226(3):652-65. PubMed ID: 20717926
[TBL] [Abstract][Full Text] [Related]
2. Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells.
Cho SW; Yang JY; Sun HJ; Jung JY; Her SJ; Cho HY; Choi HJ; Kim SW; Kim SY; Shin CS
Bone; 2009 Jun; 44(6):1069-77. PubMed ID: 19254785
[TBL] [Abstract][Full Text] [Related]
3. Suppression by glutamate of proliferative activity through glutathione depletion mediated by the cystine/glutamate antiporter in mesenchymal C3H10T1/2 stem cells.
Iemata M; Takarada T; Hinoi E; Taniura H; Yoneda Y
J Cell Physiol; 2007 Dec; 213(3):721-9. PubMed ID: 17520696
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of osteoblastogenesis through downregulation of runt-related transcription factor-2 in osteoblastic MC3T3-E1 cells with stable overexpression of the cystine/glutamate antiporter xCT subunit.
Uno K; Takarada T; Takarada-Iemata M; Nakamura Y; Fujita H; Hinoi E; Yoneda Y
J Cell Physiol; 2011 Nov; 226(11):2953-64. PubMed ID: 21302293
[TBL] [Abstract][Full Text] [Related]
5. Poncirin promotes osteoblast differentiation but inhibits adipocyte differentiation in mesenchymal stem cells.
Yoon HY; Yun SI; Kim BY; Jin Q; Woo ER; Jeong SY; Chung YS
Eur J Pharmacol; 2011 Aug; 664(1-3):54-9. PubMed ID: 21550337
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid-induced Smad3 expression is required for the induction of osteoblastogenesis of mesenchymal stem cells.
Dingwall M; Marchildon F; Gunanayagam A; Louis CS; Wiper-Bergeron N
Differentiation; 2011 Sep; 82(2):57-65. PubMed ID: 21612856
[TBL] [Abstract][Full Text] [Related]
7. Glutamate is a determinant of cellular proliferation through modulation of nuclear factor E2 p45-related factor-2 expression in osteoblastic MC3T3-E1 cells.
Uno K; Takarada T; Hinoi E; Yoneda Y
J Cell Physiol; 2007 Oct; 213(1):105-14. PubMed ID: 17443688
[TBL] [Abstract][Full Text] [Related]
8. Comparison of multipotent differentiation potentials of murine primary bone marrow stromal cells and mesenchymal stem cell line C3H10T1/2.
Zhao L; Li G; Chan KM; Wang Y; Tang PF
Calcif Tissue Int; 2009 Jan; 84(1):56-64. PubMed ID: 19052794
[TBL] [Abstract][Full Text] [Related]
9. A negative correlation between expression profiles of runt-related transcription factor-2 and cystine/glutamate antiporter xCT subunit in ovariectomized mouse bone.
Uno K; Takarada T; Nakamura Y; Fujita H; Hinoi E; Yoneda Y
J Pharmacol Sci; 2011; 115(3):309-19. PubMed ID: 21325781
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1.
Abdallah BM; Jensen CH; Gutierrez G; Leslie RG; Jensen TG; Kassem M
J Bone Miner Res; 2004 May; 19(5):841-52. PubMed ID: 15068508
[TBL] [Abstract][Full Text] [Related]
11. Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes.
Chen ZX; Chang M; Peng YL; Zhao L; Zhan YR; Wang LJ; Wang R
Regul Pept; 2007 Jul; 142(1-2):16-23. PubMed ID: 17331598
[TBL] [Abstract][Full Text] [Related]
12. Transient down-regulation of cbfa1/Runx2 by RNA interference in murine C3H10T1/2 mesenchymal stromal cells delays in vitro and in vivo osteogenesis, but does not overtly affect chondrogenesis.
Gordeladze JO; Noël D; Bony C; Apparailly F; Louis-Plence P; Jorgensen C
Exp Cell Res; 2008 Apr; 314(7):1495-506. PubMed ID: 18313048
[TBL] [Abstract][Full Text] [Related]
13. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.
Lee NJ; Doyle KL; Sainsbury A; Enriquez RF; Hort YJ; Riepler SJ; Baldock PA; Herzog H
J Bone Miner Res; 2010 Aug; 25(8):1736-47. PubMed ID: 20200977
[TBL] [Abstract][Full Text] [Related]
14. Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression.
Zhang L; Su P; Xu C; Chen C; Liang A; Du K; Peng Y; Huang D
J Pineal Res; 2010 Nov; 49(4):364-72. PubMed ID: 20738756
[TBL] [Abstract][Full Text] [Related]
15. Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat.
Kha HT; Basseri B; Shouhed D; Richardson J; Tetradis S; Hahn TJ; Parhami F
J Bone Miner Res; 2004 May; 19(5):830-40. PubMed ID: 15068507
[TBL] [Abstract][Full Text] [Related]
16. Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes.
Gharibi B; Abraham AA; Ham J; Evans BA
J Bone Miner Res; 2011 Sep; 26(9):2112-24. PubMed ID: 21590734
[TBL] [Abstract][Full Text] [Related]
17. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.
Bäckesjö CM; Li Y; Lindgren U; Haldosén LA
Cells Tissues Organs; 2009; 189(1-4):93-7. PubMed ID: 18728353
[TBL] [Abstract][Full Text] [Related]
18. Effects of overexpression of basic helix-loop-helix transcription factor Dec1 on osteogenic and adipogenic differentiation of mesenchymal stem cells.
Iwata T; Kawamoto T; Sasabe E; Miyazaki K; Fujimoto K; Noshiro M; Kurihara H; Kato Y
Eur J Cell Biol; 2006 May; 85(5):423-31. PubMed ID: 16487626
[TBL] [Abstract][Full Text] [Related]
19. Oxysterol-induced osteoblastic differentiation of pluripotent mesenchymal cells is mediated through a PKC- and PKA-dependent pathway.
Richardson JA; Amantea CM; Kianmahd B; Tetradis S; Lieberman JR; Hahn TJ; Parhami F
J Cell Biochem; 2007 Apr; 100(5):1131-45. PubMed ID: 17031848
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid-induced differentiation of primary cultured bone marrow mesenchymal cells into adipocytes is antagonized by exogenous Runx2.
Lin L; Dai SD; Fan GY
APMIS; 2010 Aug; 118(8):595-605. PubMed ID: 20666741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
